肿瘤影像学2024,Vol.33Issue(5) :470-474.DOI:10.19732/j.cnki.2096-6210.2024.05.002

诊疗一体化在物理靶向核素治疗中的应用现状及展望

The current status and prospects of theranostic in targeted radionuclide therapy

丁颖 杨辉
肿瘤影像学2024,Vol.33Issue(5) :470-474.DOI:10.19732/j.cnki.2096-6210.2024.05.002

诊疗一体化在物理靶向核素治疗中的应用现状及展望

The current status and prospects of theranostic in targeted radionuclide therapy

丁颖 1杨辉1
扫码查看

作者信息

  • 1. 郑州大学附属肿瘤医院(河南省肿瘤医院)核医学科,河南 郑州 450003;河南省肿瘤核医学精准诊疗医学重点实验室,河南 郑州 450003
  • 折叠

摘要

靶向放射性核素治疗(targeted radionuclide therapy,TRT)指通过各种手段使放射性药物在肿瘤组织内聚集的治疗方式.基于治疗方式的不同,TRT可分为化学/生物靶向内照射治疗与物理靶向内照射治疗.TRT一般指全身给药的化学/生物靶向核素治疗.随着核医学诊断治疗技术的不断发展和精准医学的推进,临床上已将分子影像与物理靶向核素治疗相结合,形成诊疗一体化的物理靶向核素治疗.本文以目前临床常见和新兴的物理靶向核素治疗为例,介绍诊疗一体化在物理靶向核素治疗中的应用现状及发展趋势.

Abstract

Targeted radionuclide therapy(TRT)leveraging the unique properties of radioactive pharmaceuticals to concentrate therapeutic effects within tumor tissues.TRT can be principally categorized into two distinct approaches based on the differences in targeting mechanisms:chemical/biological targeting internal radiotherapy and physical targeting internal radiotherapy.Generally,TRT refers to the systemic administration of targeted radionuclide drugs.The continuous advancement of nuclear medicine diagnostic and therapeutic technologies,coupled with the advocacy of precision medicine,has led to an innovative integration in clinical practice:integrated physical targeted radionuclide theranostics.This article explored the current status and development of theranostics in physically targeted radionuclide treatment,highlighting some common and emerging therapies in clinical practice.

关键词

内照射治疗/放射性核素治疗/诊疗一体化/物理靶向

Key words

Internal radiation therapy/Radionuclide therapy/Theranostics/Physically target

引用本文复制引用

出版年

2024
肿瘤影像学
复旦大学附属肿瘤医院

肿瘤影像学

CSTPCD
影响因子:0.67
ISSN:1008-617X
段落导航相关论文